Alere board’s diligence brings 51 pct premium by admin | Feb 3, 2016 | Uncategorized | 0 comments A $5.8 bln sale to $56 bln healthcare group Abbott caps a series of good decisions. Appointing a separate chairman, jettisoning Alere’s deal-hungry founder, rejecting his low-ball bid and focusing…